Does TACROLIMUS Cause Disseminated cryptococcosis? 173 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 173 reports of Disseminated cryptococcosis have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.2% of all adverse event reports for TACROLIMUS.
173
Reports of Disseminated cryptococcosis with TACROLIMUS
0.2%
of all TACROLIMUS reports
43
Deaths
130
Hospitalizations
How Dangerous Is Disseminated cryptococcosis From TACROLIMUS?
Of the 173 reports, 43 (24.9%) resulted in death, 130 (75.1%) required hospitalization, and 44 (25.4%) were considered life-threatening.
Is Disseminated cryptococcosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 173 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Disseminated cryptococcosis?
PREDNISONE (214)
MYCOPHENOLATE MOFETIL (167)
PREDNISOLONE (122)
DEXAMETHASONE (109)
METHYLPREDNISOLONE (73)
MYCOPHENOLIC ACID (59)
AMPHOTERICIN B (51)
CYCLOPHOSPHAMIDE (49)
CYCLOSPORINE (44)
RITUXIMAB (44)
Which TACROLIMUS Alternatives Have Lower Disseminated cryptococcosis Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB